Purchase Order 75N91024P00398
Award Date 9/16/24
Potential Completion Date 9/15/25
Potential Value $302K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Waltham, MA 02453, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Department of Health and Human Services, National Institutes of Health, National Cancer Institute (NCI) has awarded a $200,000 firm-fixed-price purchase order contract to Bostongene Corporation, a for-profit organization, to provide multi-omic analyses for the comprehensive interrogation of tumors using the Surgical Oncology Program's SMART system. This sole-source contract is related to a previous non-competitive procurement opportunity that was posted on August 12, 2022, with a response...
- This is a $142,990 firm fixed price purchase order contract awarded by the National Cancer Institute (NCI), a component of the National Institutes of Health (NIH), to Illumina, Inc., a manufacturer of genomic sequencing systems and analytical instruments. The contract has no set-aside designation. Illumina has previously received prime federal contract awards from other agencies like the CDC, USDA, and VA to provide sequencing systems, reagents, and related services in support of genomics...
- This firm fixed-price purchase order was awarded by the National Cancer Institute (NCI), which is part of the National Institutes of Health (NIH) under the U.S. Department of Health and Human Services (HHS), to Illumina, Inc. for $83,322.00. The contract provides for preventive maintenance, emergency service, support, and coverage for a government-owned Illumina NovaSeq 6000 sequencing system to support NCI's Comprehensive Oncologic Molecular Pathology and Sequencing Service (COMPASS) clinical...
- This is a $109,080.00 firm-fixed-price purchase order awarded by the National Cancer Institute (NCI), part of the National Institutes of Health (NIH), to Novogene Corp Inc., a minority-owned small business. The contract is for long non-coding RNA and small RNA sequencing services to identify RNA biomarkers for radiation biodosimetry. The work includes sample preparation, sequencing, and data analysis for 216 mRNA/lncRNA samples and 96 small RNA samples. This effort builds on prior successful...
- This firm fixed price BPA Call order from the National Cancer Institute, part of the National Institutes of Health within the Department of Health and Human Services, is valued at twenty-four thousand eight hundred fifty-seven dollars and eighty-four cents ($24,857.84). Prime contractor 10X Genomics, Inc. will provide single cell kits to the Chen Lab members at its Pleasanton, California location for use in single-cell analysis and research from November 16, 2022 through December 15, 2022. ...
- The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a $23,520 purchase order to Human Metabolome Technologies America, Inc. for laboratory testing services. The firm fixed price contract has a period of performance from August 22, 2023 through November 21, 2023 for work to be conducted in Boston, Massachusetts. No subcontractors or set aside designations were identified. The award provides laboratory testing support for the National...
- This is a $114,966.00 firm-fixed-price purchase order awarded by the Department of Health and Human Services (HHS), National Institutes of Health (NIH), National Cancer Institute (NCI) to Gene Square Bio-Technology LTD, a for-profit limited liability company based in China. The contract is for genetic studies of myeloid and lymphoid malignancy in China in support of NCI's Division of Cancer Epidemiology and Genetics. The work will involve scanning 2,129 DNA samples from the NCI's AsiaLymph study...
- <p>The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a $17,640 purchase order to Human Metabolome Technologies America, Inc. for testing services. The firm fixed price contract will be performed in Boston, Massachusetts over a three month period concluding in October 2023. The award provides testing services in support of the National Cancer Institute's research efforts. No subcontractors or set aside designations were identified.</p>
- The National Cancer Institute (NCI) awarded a $142,009.29 firm fixed-price purchase order contract to Fundacio Centre De Regulacio Genomica, a non-profit biomedical research institute, to perform targeted gene sequencing on samples collected by NCI's Division of Cancer Epidemiology and Genetics. This contract, which does not have a set-aside designation, is expected to be completed by June 2023. The contract was awarded in September 2021 under simplified acquisition procedures for commercial...
- This is a $24,000.00 firm fixed-price purchase order contract awarded by the National Heart, Lung and Blood Institute (NHLBI), a component of the National Institutes of Health (NIH), to Genomic Testing Cooperative, LCA, a self-certified small disadvantaged business located in Lake Forest, California. The contract is for hematology panel services, specifically the sequencing of somatic mutations in bone marrow samples to provide guidance in the treatment and diagnosis of disease. The contract has...